Physician profile
James B Piper
NPI 1114961232
$9,694.87
in general payments reported to CMS, 2019-2025
10 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $118 · 2022: $7,049 · 2023: $2,052 · 2024: $142 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Travel and Lodging: $998 · Food and Beverage: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Travel and Lodging | $998.32 |
| Food and Beverage | $333.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,078.02 | 2022-2023 | Da Vinci Surgical System, Davinci Xi |
| Genzyme Corporation | $145.04 | 2019-2020 | |
| Boston Scientific Corporation | $141.97 | 2024 | Spyglass Discover |
| Sanofi-Aventis U.S. LLC | $123.48 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $115.23 | 2019-2020 | |
| Veloxis Pharmaceuticals, INC. | $34.09 | 2020-2023 | Envarsus |
| Vifor Pharma, INC. | $24.15 | 2019 | |
| Astellas Pharma US INC | $17.61 | 2020 | |
| Medtronic, INC. | $15.28 | 2025 | Kyphon Express II Kyphopak Tray |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Piper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.